U.K.'s Brexit Seen as Bad Medicine for Pharmaceutical-Biotech Industry? An Industrial Info News Alert

SUGAR LAND, TX--(Marketwired - Jun 23, 2016) - Reported by Annette Kreuger, Industrial Info Resources, Incorporated (Sugar Land, Texas) -- On Thursday, citizens of the United Kingdom (U.K.) headed to the polls to vote on whether or not they would leave the European Union (EU). Dubbed "Brexit," a merging of the words Britain and exit, has spurred hot debate over the pros and cons of such a move. Along with other global industry sectors, the Pharmaceutical-Biotech Industry is anxiously awaiting the results, with seemingly little support for Brexit passage from within.

For details, view the entire article by subscribing to Industrial Info's Premium Industry News, or browse other breaking industrial news stories at www.industrialinfo.com.

Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, five offices in North America and 10 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the www.industrialinfo.com "Contact Us" page.

Contact:
Brian Ford
[phone]